CompletedPhase 4

Trial of Early Aggressive Drug Therapy in Juvenile Idiopathic Arthritis

United States85 participantsStarted 2007-05

Plain-language summary

The purpose of this study is to compare two aggressive drug regimens for children with poly-juvenile idiopathic arthritis (JIA) and extended oligo JIA.

Who can participate

Age range2 Years – 17 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Methotrexate duration must be less than or equal to 6 weeks at a dose of less than or equal to 0.5 mg/kg/week (40 mg max),
✕. Steroid use has been less than or equal to 4 weeks and the subject is off of steroids for at least 1 week prior to enrollment

What they're measuring

Proportion of Participants Who Attain Inactive Disease by 6 Months

Timeframe: 6 months after initiation of study intervention

Trial details

NCT IDNCT00443430

SponsorSeattle Children's Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2010-10

Results submitted2013-03-13

View on ClinicalTrials.gov More Juvenile Chronic Polyarthritis trials